Package 0615-8505-05
Brand: bupropion hydrochloride
Generic: bupropion hydrochloridePackage Facts
Identity
Package NDC
0615-8505-05
Digits Only
0615850505
Product NDC
0615-8505
Description
15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8505-05)
Marketing
Marketing Status
Brand
bupropion hydrochloride
Generic
bupropion hydrochloride
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "31890576-e68d-4449-b0dd-205175720f6b", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["aeb506f8-97c2-409a-aac9-5a73c840e8f3"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8505-05)", "package_ndc": "0615-8505-05", "marketing_start_date": "20240712"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8505-39)", "package_ndc": "0615-8505-39", "marketing_start_date": "20240315"}], "brand_name": "Bupropion Hydrochloride", "product_id": "0615-8505_31890576-e68d-4449-b0dd-205175720f6b", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0615-8505", "generic_name": "Bupropion Hydrochloride", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA211020", "marketing_category": "ANDA", "marketing_start_date": "20220801", "listing_expiration_date": "20261231"}